tiprankstipranks
Cyclopharm Limited (AU:CYC)
ASX:CYC
Australian Market

Cyclopharm Limited (CYC) Stock News & Sentiment

4 Followers
Cyclopharm’s Technegas Secures Key US Reimbursement Status
PremiumCompany Announcements
Cyclopharm’s Technegas Secures Key US Reimbursement Status
10h ago
Cyclopharm Shareholder Voting Power Shifts
PremiumCompany Announcements
Cyclopharm Shareholder Voting Power Shifts
14d ago
Cyclopharm’s Major Shareholder Sees Reduced Voting Power
PremiumCompany Announcements
Cyclopharm’s Major Shareholder Sees Reduced Voting Power
19d ago
Cyclopharm’s Technegas Gains CMS Reimbursement Status
PremiumCompany Announcements
Cyclopharm’s Technegas Gains CMS Reimbursement Status
19d ago
Cyclopharm Limited Allots Over 2 Million Shares
PremiumCompany Announcements
Cyclopharm Limited Allots Over 2 Million Shares
20d ago
Cyclopharm Shareholders Approve Key Resolutions
PremiumCompany Announcements
Cyclopharm Shareholders Approve Key Resolutions
20d ago
Cyclopharm Director Buys 10,000 Company Shares
PremiumCompany Announcements
Cyclopharm Director Buys 10,000 Company Shares
21d ago
More AU:CYC News >

CYC News on the Web

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:CYC’s Media Buzz Sentiment?
Currently, no data Available
What is AU:CYC’s weekly average amount of articles?
Currently, no data Available
What is AU:CYC’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
SRPTSarepta Therapeutics
ITCIIntra-Cellular Therapies
DAWNDay One Biopharmaceuticals
SILKSilk Road Medical
GILDGilead Sciences
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis